FDA Staff Says Decitabine No Help in AML

WASHINGTON (MedPage Today) — Decitabine (Dacogen), a hypomethylating agent, does not appear to improve mortality in older patients with acute myelogenous leukemia, FDA reviewers concluded.

Fighters Need Padded Gear to Cut Head Injury (CME/CE)

(MedPage Today) — Rotational head injuries in fighting sports can be minimized if participants wear padded boxing gloves and headgear rather lighter protective gear or no protection at all, a laboratory study suggested.

Bread, Bologna, Cheese Top List of Salty Foods

(MedPage Today) — Just 10 types of food account for nearly half of the nation’s excessive sodium intake, government researchers found.

FDA Issues Warning on Acid Reflux Drugs

(MedPage Today) — The FDA warned today that use of proton pump inhibitors — including popular brands such as Nexium, Prilosec, and Prevacid — may increase the risk of Clostridium difficile-associated diarrhea.

Child Abuse Linked to High Financial Burden

Lifetime medical costs for abused kids outstrip those for type 2 diabetes and stroke. Medscape Medical News

Drug Shortages for Infectious Diseases Are Increasing

A new study shows a rising number of drugs for infectious diseases that are in short supply, with serious consequences. Medscape Medical News

Bread, Bologna, and Cheese Top List of Salty Foods

(MedPage Today) — Just 10 types of food account for nearly half of the nation’s excessive sodium intake, government researchers found.

All Sides Agree: Tax Law Doesn’t Apply to ACA

WASHINGTON (MedPage Today) — The Obama administration and plaintiffs suing the federal government over the Affordable Care Act at least see eye-to-eye on one thing: A federal tax law shouldn’t bar the Supreme Court from ruling on case.

Merck Drug Cuts CV Risk, Increases Bleeds

(MedPage Today) — The investigational anticoagulant vorapaxar significantly reduced cardiovascular events, but at the expense of intracranial hemorrhage, according to top-line results announced today by drugmaker Merck.

Ovarian Cancer Screening Common Despite Lack of Proof (CME/CE)

(MedPage Today) — More than 90% of primary care physicians reported ordering ovarian cancer screening tests not recommended for women with a low or average risk for the disease, a national survey showed.